{
    "version": "1.0",
    "type": "rich",
    "width": "",
    "height": "",
    "title": "Imfinzi og BCG-immunterapi ga færre tilbakefall for høyrisiko blærekreft-pasienter: – Lovende",
    "url": "https://www.healthtalk.no/kreft/imfinzi-og-bcg-immunterapi-ga-faerre-tilbakefall-for-hoyrisiko-blaerekreft-pasienter-lovende/204232",
    "author_name": "healthtalk",
    "author_url": "https://www.healthtalk.no",
    "provider_name": "Labrador",
    "provider_url": "http://www.labradorcms.com/",
    "html": "<div class=\"labrador-cms-embed\" data-lab-style=\" dac-embed-full\" data-lab-content=\"full\" data-lab-id=\"204232\" data-lab-site=\"www.healthtalk.no\"><script async defer src=\"https://www.healthtalk.no/embed.js?v=335\"></script></div>"
}